Alpha Compute Corp (NasdaqCM: ALP)
Health Care · Biotechnology · VG
$0.16
+0.52% today · -98.1% 1Y
Alpha Compute Corp (NasdaqCM: ALP) operates in the Biotechnology industry within the Health Care sector. The company is valued at $3.63M and employs 22 people.
Over the last twelve months the share price has lost 98.1%, trading between 0.14 and 13.80.
Tweenvest scores Alpha Compute Corp across four factors: quality 20/100, value 51/100. Its strongest factor is value.
ALP price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $3.63M
- Revenue (TTM)
- $97.00K
- P/E
- —
- EPS
- -4.18
- Dividend yield
- —
- Beta (5Y)
- 0.55
- 52-week high
- $13.80
- 52-week low
- $0.14
- Avg volume (3M)
- —
- Shares outstanding
- 23.47M
- Employees
- 22
- Next earnings
- —
About Alpha Compute Corp
Alpha Compute Corp. (Nasdaq: ALP) is a high-performance GPU infrastructure and confidential-compute technology company built for the artificial intelligence economy. Structured as a holding company focused on sovereign AI compute, Alpha Compute owns the infrastructure that powers modern intelligence and enforces privacy directly at the hardware level. That foundation positions the company to build and acquire businesses that depend on confidential compute and artificial intelligence. Alpha Compute's mission is to support clients, subsidiaries, and partners across critical sectors such as finance, defense, intelligence, and media as they adapt to a rapidly changing AI landscape. The company provides the core framework any organization needs to run secure, confidential computing environments. Alpha Compute is domiciled in the British Virgin Islands, with offices in New York, Los Angeles, Miami, Amsterdam, and Toronto.
- ISIN
- VGG7185A1369
- Listed since
- Jan 2, 2002
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $467.44B | $264.52 | 0.00% |
| Amgen Inc.NasdaqGS: AMGN | $239.95B | $445.53 | +0.38% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.95B | $146.74 | +0.42% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.79B | $547.59 | -0.08% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $82.73B | $828.50 | -0.66% |
| argenx SEENXTBR: ARGX | $63.06B | €874.40 | +1.18% |
| CSL LimitedASX: CSL | $57.94B | AU$169.11 | +0.48% |
| Moderna, Inc.NasdaqGS: MRNA | $55.45B | $141.11 | +1.60% |
Figures last refreshed Aug 18, 2026.